Related Experiment Video
Updated: Dec 4, 2025

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
Małgorzata Kloc1,2,3, Rafik M Ghobrial1,2, Sławomir Lewicki4
1The Houston Methodist Research Institute, 6670 Bertner Ave, Houston, TX 77030 USA.
Abstract:
Diabetes mellitus (DM) augments the risk of hospitalization and mortality resulting from viral, bacterial, or fungal pathogen infection. This has been also true for the past SARS and MERS, and current SARS-CoV-2 coronavirus epidemics. Clinical data indicate that SARS-CoV-2 infection triggers a severe course of COVID-19 more frequently in diabetic than non-diabetic patients. Here we overview the cellular and molecular mechanisms associated with this phenomenon. We focus on alterations in the immune cells, especially monocytes and macrophages, involved in innate immune response and inflammatory processes, which differ in type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). We also describe the DM-related changes in the monocyte/macrophages functions, how they could lead to the severe outcome of SARS-CoV-2 infection, and importantly, if and how they could initiate DM in DM-susceptible patients.
Insights
Diabetes mellitus (DM) increases severe COVID-19 risk by altering immune cells like monocytes and macrophages. Understanding these changes in type 1 and type 2 diabetes is crucial for managing SARS-CoV-2 infection.
Area of Science:
- Immunology
- Endocrinology
- Infectious Diseases
Background:
- Diabetes mellitus (DM) is linked to increased hospitalization and mortality from infections, including viral epidemics like SARS-CoV-2.
- COVID-19 severity is notably higher in diabetic patients compared to non-diabetic individuals.
Purpose of the Study:
- To overview the cellular and molecular mechanisms underlying the heightened risk of severe COVID-19 in diabetic patients.
- To explore the distinct immune cell alterations in type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) concerning SARS-CoV-2 infection.
- To investigate how DM-associated changes in monocyte/macrophage function may contribute to severe COVID-19 outcomes and potentially initiate DM.
Main Methods:
- Review of existing clinical data and scientific literature on diabetes mellitus and infectious diseases.
- Focus on cellular and molecular mechanisms involving innate immune response and inflammatory processes.
- Analysis of monocyte and macrophage function alterations in T1DM and T2DM.
Main Results:
- Diabetic patients exhibit a higher incidence of severe COVID-19 outcomes.
- Specific alterations in monocytes and macrophages, differing between T1DM and T2DM, are implicated in the immune response to SARS-CoV-2.
- Dysfunctional immune cells may contribute to severe COVID-19 and potentially influence DM susceptibility.
Conclusions:
- Immune cell dysregulation in diabetes mellitus significantly impacts the severity of SARS-CoV-2 infection.
- Understanding these mechanisms is vital for developing targeted interventions for diabetic patients during viral epidemics.
- Further research is needed to elucidate the role of these immune changes in DM initiation.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

